Cite
MLA Citation
Claus F. Vogelmeier et al.. “Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial.” Therapeutic advances in respiratory disease, vol. 14, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100113142148.0x0000f0